ELIQUIS vs ELRANATAMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ELIQUIS vs ELRANATAMAB: Safety Overview
| Metric | ELIQUIS | ELRANATAMAB |
|---|---|---|
| Total FAERS Reports | 1,430 | 758 |
| Deaths Reported | 98 | 177 |
| Death Rate | 6.9% | 23.4% |
| Hospitalizations | 273 | 482 |
| Average Patient Age | 76.5 yrs | 67.6 yrs |
| % Female Patients | 100.0% | 45.2% |
| Manufacturer | N/A | Pfizer Laboratories Div Pfizer Inc |
| Route | N/A | SUBCUTANEOUS |
| Marketing Status | N/A | Prescription |